OncoSec Medical: The Microcap Biotech With The Billion Dollar Immuno-Oncology Solution

Home › OncoSec Medical: The Microcap Biotech With The Billion Dollar Immuno-Oncology Solution

Only small number of patients respond to PD-1 inhibitors. OncoSec ImmunoPulse IL-12 aimed at turning non-responders into responders.

04.11	Registration Open for 2025 Waterborne Symposium
04.11	ROSS Ribbon Blenders Provide Safe, Efficient Bulk Blending
04.11	Natracare Launches E-Commerce Site
04.11	Tropical Depression Eighteen Graphics
04.11	The Honey Pot Launches Witch Hazel Intimate Wash & Wipes
04.11	Remnants of Patty Graphics
04.11	Tropical Depression Eighteen Forecast Discussion Number 4
04.11	Remnants of Patty Forecast Discussion Number 10
More »

je.st